204 related articles for article (PubMed ID: 20230085)
1. BDNF genotype moderates the relation between physical activity and depressive symptoms.
Mata J; Thompson RJ; Gotlib IH
Health Psychol; 2010 Mar; 29(2):130-3. PubMed ID: 20230085
[TBL] [Abstract][Full Text] [Related]
2. Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancer.
Dooley LN; Ganz PA; Cole SW; Crespi CM; Bower JE
J Affect Disord; 2016 Jun; 197():43-50. PubMed ID: 26967918
[TBL] [Abstract][Full Text] [Related]
3. Interacting effect of BDNF Val66Met polymorphism and stressful life events on adolescent depression.
Chen J; Li X; McGue M
Genes Brain Behav; 2012 Nov; 11(8):958-65. PubMed ID: 22931410
[TBL] [Abstract][Full Text] [Related]
4. Interaction between job stress and the BDNF Val66Met polymorphism affects depressive symptoms in Chinese healthcare workers.
He SC; Wu S; Wang C; Du XD; Yin G; Jia Q; Zhang Y; Wang L; Soares JC; Zhang XY
J Affect Disord; 2018 Aug; 236():157-163. PubMed ID: 29734099
[TBL] [Abstract][Full Text] [Related]
5. The BDNF Val66Met polymorphism does not moderate the effect of self-reported physical activity on depressive symptoms in midlife.
Gujral S; Manuck SB; Ferrell RE; Flory JD; Erickson KI
Psychiatry Res; 2014 Aug; 218(1-2):93-7. PubMed ID: 24745471
[TBL] [Abstract][Full Text] [Related]
6. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.
Aguilera M; Arias B; Wichers M; Barrantes-Vidal N; Moya J; Villa H; van Os J; Ibáñez MI; Ruipérez MA; Ortet G; Fañanás L
Psychol Med; 2009 Sep; 39(9):1425-32. PubMed ID: 19215635
[TBL] [Abstract][Full Text] [Related]
7. The interacting effect of the BDNF Val66Met polymorphism and stressful life events on adolescent depression is not an artifact of gene-environment correlation: evidence from a longitudinal twin study.
Chen J; Li X; McGue M
J Child Psychol Psychiatry; 2013 Oct; 54(10):1066-73. PubMed ID: 23848344
[TBL] [Abstract][Full Text] [Related]
8. The BDNF Val66Met polymorphism predicts rumination and depression differently in young adolescent girls and their mothers.
Hilt LM; Sander LC; Nolen-Hoeksema S; Simen AA
Neurosci Lett; 2007 Dec; 429(1):12-6. PubMed ID: 17959306
[TBL] [Abstract][Full Text] [Related]
9. Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse.
Grabe HJ; Schwahn C; Mahler J; Appel K; Schulz A; Spitzer C; Fenske K; Barnow S; Freyberger HJ; Teumer A; Petersmann A; Biffar R; Rosskopf D; John U; Völzke H
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):264-70. PubMed ID: 21996278
[TBL] [Abstract][Full Text] [Related]
10. BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: a prospective study.
Buchmann AF; Hellweg R; Rietschel M; Treutlein J; Witt SH; Zimmermann US; Schmidt MH; Esser G; Banaschewski T; Laucht M; Deuschle M
Eur Neuropsychopharmacol; 2013 Aug; 23(8):902-9. PubMed ID: 23058261
[TBL] [Abstract][Full Text] [Related]
11. The BDNF Val66Met Polymorphism Interacts with Maternal Parenting Influencing Adolescent Depressive Symptoms: Evidence of Differential Susceptibility Model.
Zhang L; Li Z; Chen J; Li X; Zhang J; Belsky J
J Youth Adolesc; 2016 Mar; 45(3):471-83. PubMed ID: 26510938
[TBL] [Abstract][Full Text] [Related]
12. Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression.
Duncan LE; Hutchison KE; Carey G; Craighead WE
J Affect Disord; 2009 May; 115(1-2):215-9. PubMed ID: 18842305
[TBL] [Abstract][Full Text] [Related]
13. BDNF Val66Met polymorphism is associated with Stage III-IV endometriosis and poor in vitro fertilization outcome.
Zhang QY; Guan Q; Wang Y; Feng X; Sun W; Kong FY; Wen J; Cui W; Yu Y; Chen ZY
Hum Reprod; 2012 Jun; 27(6):1668-75. PubMed ID: 22447624
[TBL] [Abstract][Full Text] [Related]
14. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression.
Montag C; Weber B; Fliessbach K; Elger C; Reuter M
Psychol Med; 2009 Nov; 39(11):1831-9. PubMed ID: 19335934
[TBL] [Abstract][Full Text] [Related]
15. Interactions between the combined genotypes of 5-HTTLPR and BDNF Val66Met polymorphisms and parenting on adolescent depressive symptoms: A three-year longitudinal study.
Wang M; Tian X; Zhang W
J Affect Disord; 2020 Mar; 265():104-111. PubMed ID: 32090731
[TBL] [Abstract][Full Text] [Related]
16. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
[TBL] [Abstract][Full Text] [Related]
17. BDNF Val66Met and childhood adversity on response to physical exercise and internet-based cognitive behavioural therapy in depressed Swedish adults.
Rahman MS; Millischer V; Zeebari Z; Forsell Y; Lavebratt C
J Psychiatr Res; 2017 Oct; 93():50-58. PubMed ID: 28578208
[TBL] [Abstract][Full Text] [Related]
18. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
[TBL] [Abstract][Full Text] [Related]
19. Association of functional polymorphisms from brain-derived neurotrophic factor and serotonin-related genes with depressive symptoms after a medical stressor in older adults.
Rawson KS; Dixon D; Nowotny P; Ricci WM; Binder EF; Rodebaugh TL; Wendleton L; Doré P; Lenze EJ
PLoS One; 2015; 10(3):e0120685. PubMed ID: 25781924
[TBL] [Abstract][Full Text] [Related]
20. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
Matsuo K; Walss-Bass C; Nery FG; Nicoletti MA; Hatch JP; Frey BN; Monkul ES; Zunta-Soares GB; Bowden CL; Escamilla MA; Soares JC
Neuropsychopharmacology; 2009 Jul; 34(8):1904-13. PubMed ID: 19295510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
